Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple‐blind randomized clinical trial
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8037 ↗At a glance
Randomisierte kontrollierte Studie in Phytotherapy Research, 2024. Written by Masoome Jabarpour and 3 co-authors. Institution: Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Major MEDLINE topics: Insulin Resistance, Polycystic Ovary Syndrome, Infertility, Female. Cited 31 times so far (Crossref); 68 references. Funded by: Tehran University of Medical Sciences and Health Services.
Abstract (original language)
Astaxanthin (ASX) is a natural carotenoid compound found in several of microorganisms and seafood. It may have numerous therapeutic benefits for polycystic ovarian syndrome (PCOS) patients. The aim of this study was to investigate the effect of ASX on lipid profile, insulin resistance (IR), blood pressure (BP), and oxidative stress (OS) levels in infertile PCOS patients. Overall, 58 infertile women with diagnosed PCOS participated in this triple‐blind randomized clinical trial. They were randomly assigned to two groups, taking either a placebo or ASX (2 × 6 mg/day) for 8 weeks. Blood serum samples were collected from patients before and after the intervention. Fasting Insulin (FI), fasting blood glucose (FBS), OS markers (malondialdehyde [MDA], superoxide dismutase [SOD], and total antioxidant capacity [TAC]), and lipid profiles were evaluated in serum. Moreover, based on the relevant formula, several indices associated with IR were calculated. BP was also assessed at the start and end of the study. After 8 weeks of ASX consumption, a significant reduction was observed in fasting blood sugar, HOMA‐IR, FI, MDA, low‐density lipoprotein‐cholesterol, and TC/HDL‐C. Conversely, ASX significantly increased TAC, HDL‐C, and QUICKI. After adjusting the analysis for the baseline values of age, body mass index, and biochemical parameters, non‐significant values were obtained for QUICKI and FI, along with no changes in other findings. Overall, ASX appears to be an effective and safe supplement that alleviates insulin metabolism, lipid profile parameters, and OS in infertile PCOS patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Infertility, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Infertility, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.
ORCID profiles: Masoome Jabarpour, Fardin Amidi
Funding
- Tehran University of Medical Sciences and Health Services
Cite
APA
Jabarpour, M., Aleyasin, A., Shabani Nashtaei, M., & Amidi, F. (2024). Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple‐blind randomized clinical trial. Phytotherapy Research. https://doi.org/10.1002/ptr.8037
Vancouver
Jabarpour M, Aleyasin A, Shabani Nashtaei M, Amidi F. Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple‐blind randomized clinical trial. Phytotherapy Research. 2024. doi:10.1002/ptr.8037
BibTeX
@article{Jabarpour2024,
author = {Jabarpour, Masoome and Aleyasin, Ashraf and Shabani Nashtaei, Maryam and Amidi, Fardin},
title = {Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple‐blind randomized clinical trial},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8037}
}
EUVIMED